Loading organizations...
Crossroads Fund operates as a public foundation that provides grants to community organizations in the Chicago area, focusing on racial, social, and economic justice. It supports innovative, grassroots organizing models often overlooked by other funders, while also building movements through workshops, capacity-building, and public platforms that amplify grantee efforts.
Established in 1981, Crossroads Fund was founded on the conviction that profound social change stems from community-led initiatives. This belief underpins its activist-informed grantmaking process, where decisions involve input from grantees and community members, ensuring resources are strategically directed toward effective grassroots groups addressing systemic issues.
The foundation serves grassroots organizations working towards collective liberation by transforming unjust conditions. Crossroads Fund aims to strengthen leadership and foster sustainable communities by creating robust relationships among donors, grantees, and community members. Its long-term vision is to support transformative social change by challenging established power structures.
Crossroad Fund has 1 tracked investment across 1 company. The latest tracked deal is $10.0M Series C in Regentis Biomaterials in May 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 14, 2012 | Regentis Biomaterials | $10.0M Series C | — | Medica Venture Partners, Royal DSM, SCP Vitalife Partners, Technion |